As of 3:59pm ET
| 0.00 / 0.00%|
The 5 analysts offering 12-month price forecasts for Galena Biopharma Inc have a median target of 5.00, with a high estimate of 8.00 and a low estimate of 2.00. The median estimate represents a +216.46% increase from the last price of 1.58.
The current consensus among 6 polled investment analysts is to Buy stock in Galena Biopharma Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.